Evidence map›Paper›PMID 40550846›Full record

ArticleLeukemia2025

Mutations and translocations associated with venetoclax resistance in chronic lymphocytic leukemia.

Kiyomi Mashima, Yanan Kuang, Stacey M Fernandes, Shidong Xu, Benjamin Hanna, Samantha Shupe, Mariia Mikhaleva, Roberta Azevedo Santos, Paulina Predko, Rayan Fardoun and 6 more

Abstract read
PubMed Publisher
In one paragraph

Article in Leukemia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Kiyomi MashimaDepartment of Medical Oncology, CLL Center, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0002-4736-3285
Yanan KuangDepartment of Medical Oncology, CLL Center, Dana-Farber Cancer Institute, Boston, MA, USA.
Stacey M FernandesDepartment of Medical Oncology, CLL Center, Dana-Farber Cancer Institute, Boston, MA, USA.
Shidong XuDepartment of Medical Oncology, CLL Center, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID http://orcid.org/0009-0003-6800-0939
Benjamin HannaDepartment of Medical Oncology, CLL Center, Dana-Farber Cancer Institute, Boston, MA, USA.
Samantha ShupeDepartment of Medical Oncology, CLL Center, Dana-Farber Cancer Institute, Boston, MA, USA.
Mariia MikhalevaDepartment of Medical Oncology, CLL Center, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0002-2135-2051
Roberta Azevedo SantosDepartment of Medical Oncology, CLL Center, Dana-Farber Cancer Institute, Boston, MA, USA.
Paulina PredkoDepartment of Medical Oncology, CLL Center, Dana-Farber Cancer Institute, Boston, MA, USA.
Rayan FardounDepartment of Medical Oncology, CLL Center, Dana-Farber Cancer Institute, Boston, MA, USA.
Ava BidgoliDepartment of Medical Oncology, CLL Center, Dana-Farber Cancer Institute, Boston, MA, USA.
Stephen P MartindaleDepartment of Medical Oncology, CLL Center, Dana-Farber Cancer Institute, Boston, MA, USA.
Aishath NaeemDepartment of Medical Oncology, CLL Center, Dana-Farber Cancer Institute, Boston, MA, USA.
Matthew S DavidsDepartment of Medical Oncology, CLL Center, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0003-4529-2003
Cloud PaweletzDepartment of Medical Oncology, CLL Center, Dana-Farber Cancer Institute, Boston, MA, USA.
Jennifer R BrownDepartment of Medical Oncology, CLL Center, Dana-Farber Cancer Institute, Boston, MA, USA. Jennifer_Brown@dfci.harvard.edu.

Funding

Genetic Predisposition to Chronic Lymphocytic Leukemia (CLL)R01CA258924 · NCI · DANA-FARBER CANCER INST · PI BROWN, JENNIFER R · 2021 to 2025
$3.1M
Unlocking the Potential of PI3K Inhibition in CLLR01CA213442 · NCI · DANA-FARBER CANCER INST · PI BROWN, JENNIFER R · 2017 to 2021
$2.9M
U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R01CA213442U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R01CA258924
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40550846

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.